{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:18:11Z","timestamp":1770135491764,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","award":["2060-2551\/13-1"],"award-info":[{"award-number":["2060-2551\/13-1"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","award":["0001\/2013"],"award-info":[{"award-number":["0001\/2013"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jgar.2017.12.013","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T13:46:48Z","timestamp":1515073608000},"page":"180-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["High frequency of aac(6 \u2032 )-Ib -cr gene associated with double mutations in gyrA and parC in Escherichia coli isolates from patients with urinary tract infections"],"prefix":"10.1016","volume":"13","author":[{"given":"Lisiane M.","family":"Volc\u00e3o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliano P.","family":"Lacava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina F.","family":"Gewehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria L.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivy B.","family":"Ramis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla V.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia G.","family":"Possuelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciene A.R.","family":"Minarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro E.A.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6727-372X","authenticated-orcid":false,"given":"Andrea","family":"von Groll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2017.12.013_bib0005","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ajic.2014.05.029","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module","volume":"42","author":"Rosenthal","year":"2014","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2017.12.013_bib0010","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jac\/dkt063","article-title":"Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu","volume":"68","author":"Dom\u00ednguez-Herrera","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.12.013_bib0015","series-title":"Antimicrobial resistance. Global report on surveillance 2014","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.jgar.2017.12.013_bib0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijantimicag.2010.11.022","article-title":"Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates","volume":"37","author":"Bansal","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2017.12.013_bib0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijmm.2013.02.001","article-title":"Plasmids and the spread of resistance","volume":"303","author":"Carattoli","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.jgar.2017.12.013_bib0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(06)70599-0","article-title":"The worldwide emergence of plasmid-mediated quinolone resistance","volume":"6","author":"Robicsek","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2017.12.013_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.17058\/reci.v6i1.6574","article-title":"Factors associated with ciprofloxacin and levofloxacin resistance in Gram-negative bacilli isolated from urinary tract infections","volume":"6","author":"Volc\u00e3o","year":"2016","journal-title":"Revista de Epidemiologia e Controle de Infec\u00e7\u00e3o"},{"key":"10.1016\/j.jgar.2017.12.013_bib0040","series-title":"Resolu\u00e7\u00e3o da Diret\u00f3ria Colegiada n\u00b0 344, de 12 de maio de 1998. Disp\u00f5e sobre o controle de medicamentos \u00e0 base de subst\u00e2ncias classificadas como antimicrobianos, de uso sob prescri\u00e7\u00e3o m\u00e9dica, isoladas ou em associa\u00e7\u00e3o e d\u00e1 outras provid\u00eancias","author":"Minist\u00e9rio da Sa\u00fade de Brasil","year":"1998"},{"key":"10.1016\/j.jgar.2017.12.013_bib0045","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.jgar.2017.12.013_bib0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jac\/dkm204","article-title":"Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates","volume":"60","author":"Cattoir","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.12.013_bib0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jac\/dkn237","article-title":"Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil","volume":"6","author":"Minarini","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.12.013_bib0060","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.bmc.2012.02.039","article-title":"Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis","volume":"20","author":"Gr\u00f6blacher","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jgar.2017.12.013_bib0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1590\/S0074-02762012000500018","article-title":"The first report of the qnrB19, qnrS1 and aac(6\u02b9)-Ib-cr genes in urinary isolates of ciprofloxacin-resistant Escherichia coli in Brazil","volume":"107","author":"Paiva","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jgar.2017.12.013_bib0070","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1099\/jmm.0.055970-0","article-title":"Extended-spectrum \u03b2-lactamases in Enterobacteriaceae isolated in Brazil carry distinct types of plasmid-mediated quinolone resistance genes","volume":"62","author":"Viana","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2017.12.013_bib0075","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/0255-0857.103766","article-title":"Plasmid-mediated quinolone resistance determinates qnr, aac(6\u02b9)-Ib-cr and qep in ESBL-producing Escherichia coli clinical isolates from Egypt","volume":"30","author":"Hassan","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jgar.2017.12.013_bib0080","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/AAC.01615-12","article-title":"Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina","volume":"57","author":"Adres","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.12.013_bib0085","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2017.12.013_bib0090","first-page":"3230","article-title":"Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections","volume":"47","author":"Lindgren","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.12.013_bib0095","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AAC.49.6.2343-2351.2005","article-title":"Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections","volume":"49","author":"Lindgren","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.12.013_bib0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/JCM.00827-10","article-title":"Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli strains clinically isolated from urinary tract infection patients","volume":"49","author":"Yasufuku","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517302436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517302436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T18:24:36Z","timestamp":1535135076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716517302436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":20,"alternative-id":["S2213716517302436"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2017.12.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High frequency of aac(6\u2032)-Ib-cr gene associated with double mutations in gyrA and parC in Escherichia coli isolates from patients with urinary tract infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2017.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}